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haracterization of ertapenem resistance in Klebsiella
neumoniae from Croatia
. Bedenic1,∗, J. Vranes2, Z. Bosnjak3, A. Budimir4, S.
alenic3
School of Medicine, University of Zagreb, Clinical Hospital
enter Zagreb, Zagreb, Croatia
Zagreb Institue of Public Health ‘‘Andrija Stampar’’,
agreb, Croatia
Clinical Hospital Center Zagreb, Zagreb, Croatia
School of Medicine University of Zagreb, Clinical Hospital
enter Zagreb, Zagreb, Croatia
Background: Klebsiella pneumoniae isolates with
educed susceptibility to carbapenems were recently
eported in USA, UK, Turkey and some other countries of
he world. Recently eight Klebsiella pneumoniae strains
ith reduced susceptibility to carbapenems were isolates
n four different hospitals in Croatia. The aim of the study
as to determine the mechanisms of ertapenem resistance
n these strains.
Methods: Antibiotic susceptibilities were determined by
roth microdilution method according to CLSI. Transferabil-
ty of ertapenem resistance was determined by conjugation
broth mating method) using E. coli A15 R- as recip-
ent. Production of metallo -lactamases was detected
y double-disk synergy test and E test. B-lactamases
ere characterized by PCR with primers speciﬁc for
xtended-spectrum -lactamases, plasmid-mediated ampC
-lactamases, metallo -lactamases of VIM and IMP series,
PC and OXA-48 -lactamases. Genotyping of the strains was
erformed by PFGE.
Results: All strains were resistant to ceftazidime,
efotaxime, ceftriaxone, piperacillin alone and combined
ith tazobactam, amoxycillin/clavulanate, gentamicin and
iproﬂoxacin. All except one strains showed resistance
o ertapenem, intermediate susceptibility or resistance to
eropenem and intermediate susceptibility or full suscep-
iblity to imipenem. One strain was resistant to all three
arbapenems. Ertapenem resistance was not transferable
y conjugation to E. coli recipient in neither of our strains.
CR revealed the presence of blaSHV and blaCTX-M genes.
ultiplex PCR was positive for group 1 CTX-M -lactamases.
equencing of representative blaCTX-M genes revealed the
resence of CTX-M-15 betalactamase. The strain resistant to
ll three carbapenem was positive by E test for MBLs. How-
ver, PCR was negative for VIM and IMP -lactamases. No
PC or plasmid-mediated ampC -lactamases were found.
he strains were not clonally related as shown by PFGE and
isplayed distinct PFGE ﬁngerprints.
Conclusion: This is the ﬁrst report of carbapenem
esistant Klebsiellae in Croatia. Ertapenem resistance in
lebsiella was previously reported in UK, Turkey and Israel
ainly due to the production of CTX-M $-lactamases of group
combined with porin loss (OmpK36 or OmpK35). The char-
cterization of outer membrane porins needs to be done
o clarify the mechanisms of ertapenem resistance in our
trains. Further testing is necessary to determine the mech-
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nism of carbapenem resistance in the strain with positive
test—MBL.
oi:10.1016/j.ijid.2010.02.1561
3.006
hanging trends in antimicrobial resistance among
almonella serotypes in Southern India
. rao1,∗, B. Kabir2
kasturba Medical College & Hospital,Manipal, Karnataka,
ndia
Kasturba Medical College and Hospital, Madhav Nagar,
anipal, India
Background: Enteric fever caused by drug resistant
almonella enterica serotype Typhi and Salmonella enter-
ca serotype Paratyphi A has been the major public health
oncern in the Indian Subcontinent.
Methods: A Retrospective analysis of antibiogram and
esistance pattern to Ciproﬂoxacin, Nalidixic acid, Ceftriax-
ne Azithromicin and other routine antibiotics to Salmonella
solates from PUO cases from blood cultures during 2005-
006 combined with a follow up during 2007-2008 represents
he data presented in this study.
Results: Of the 2247 from PUO cases 198 salmonella
pecies (65 were Salmonella typhi, 132 Salmonella paraty-
hi A and 1 Salmonella enteritidis. Salmonella typhi and
almonella paratyphi A serotypes were sensitive to Chlo-
amphenicol, Ampicillin, Cotrimoxazole, and Cefriaxone
nd sensitive /intermediate to Ciproﬂoxacin and resistant
o Nalidixic acid (except one). MIC for Ciproﬂoxacin and
alidixic acid resistance strains was 0.5/1 g/ml except for
MDR salmonella strains which had MIC value of 16 g/ml.
his was reﬂected on disc diffusion test as intermediate zone
f inhibition. Retrospective blood culture analysis of 2005-
006 has shown that MDR Salmonella typhi was common
solate then and the strains were sensitive for Ciproﬂoxacin
MIC being 0.125g/ml). No antibiotic resistant Salmonella
aratyphi A was isolated during this period.
Conclusion: Salmonella strains with Nalidixic acid resis-
ance and reduced susceptibility and MIC to Ciproﬂoxacin
ave emerged as major cause of enteric fever in Indian Sub-
ontinent. Nalidixic acid susceptibility (30g disc) can be
eliably used to monitor Ciproﬂoxacin resistance.
oi:10.1016/j.ijid.2010.02.1562
3.007
olecular epidemiology of aminoglycosides resistance
n Acinetobacter spp. with emergence of multidrug-
esistant strains in hospitalized patients in Iran
. Moniri ∗, R. Kheltabadi Farahani
Kashan University of Medical Sciences, Kashan, Iran, Islamic
epublic of
Background: Acinetobacter spp. is emerging as an impor-
ant nosocomial pathogen and is characterized by increasing
ntimicrobial resistance. Our aim was to evaluate antimicro-
ial susceptibility and aminoglycosides resistance genes of
cinetobacter spp. isolated from hospitalized patients.
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Methods: Sixty isolates were identiﬁed as Acinetobacter
species. The isolates were tested for antibiotic resistance by
disc diffusion method for 12 antimicrobials. The presence of
aphA6, aacC1 aadA1, and aadB genes were detected using
PCR.
Results: From the isolated Acinetobacter spp. the highest
resistance rate showed against amikacin, tobramycin, and
ceftazidim, respectively; while isolated bacteria were more
sensitive to ampicillic/subactam. More than 66% of the iso-
lates were resistant to at least three classes of antibiotics,
and 27.5% of MDR strains were resistant to all seven tested
classes of antimicrobials. The higher MDR rate presented
in bacteria isolated from the ICU and blood samples. More
than 60% of the MDR bacteria were resistance to amikacin,
ceftazidim, ciproﬂoxacin, piperacillin/tazobactam, doxy-
cycline, tobramycin and levoﬂoxacin. Also, more than
60% of the isolates contained phosphotransferase aphA6,
and acetyltransferase genes aacC1, but adenylyltransferase
genes aadA1 (41.7%), and aadB (3.3%) were less prominent.
In this study 21.7% of the strains contain three aminoglyco-
side resistance genes (aphA6, aacC1 and aadA1).
Conclusion: The rising trend of resistance to amino-
glycosides poses an alarming threat to treatment of such
infections. The ﬁndings showed that clinical isolates of
Acinetobacter spp. in our hospital carrying various kinds of
aminoglycoside resistance genes.
doi:10.1016/j.ijid.2010.02.1563
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Incidence of Carbapanemase Resistance Gene (KPC)
among Klebsiella pneumoniae isolates and its Clinical
Implications
B. Yegneswaran ∗, W. Numsuwan, D. Alcid
Drexel University College of Medicine / St Peter’s University
Hospital, New Brunswick, NJ, USA
Background: Carbapenem antibiotics (Imipenem,
Ertapenem, and Meropenem) idicated for infections caused
by extended-spectrum {beta}-lactamase (ESBL) carrying
pathogens. Carbapenem resistance has been unusual in
isolates of Klebsiella pneumoniae. The aim of this study
is to identify the prevalence of KPC positive Klebsiella
pneumoniae, and it’s clinical signiﬁcance.
Methods: All isolates of Klebsiella pneumoniae species
from October 1, 2007 to September 30, 2009 were tested
for the presence of KPC gene using the modiﬁed Hodge test.
Medical records of patients with KPC were studied.
Results: Over the period of two-years 40,309 samples
were submitted for culture and sensitivity, out of which
7,836 were positive. Of the positives, there were 106 iso-
lates of K pneumoniae and 11 were ESBL positive. Of
the ESBL producing isolates, 8 carried the Carbapenem-
hydrolyzing -lactamase. Of the eight, three isolates were
reported as being susceptible to Imipenem. Although all
the eight isolates were resistant using the Hodge test.
Piperacillin/Tazobactam (PT) and Vancomycin were the
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ntibiotic used 7 of the 8 patients prior to isolation
f Klebsiella pneumoniae resistant to Carbapenems. One
atient was excluded in outcome as one patient’s sam-
le was clinically thought to be a contaminant was not
reated. 3 patients in whom resistance to carbapenem was
eported had their antibiotic was changed to Tigecycline
nd Polymyxin B resulting in clinical improvement. Of the
emaining 4 patients who were reported as sensitive to car-
apenem three patients had to undergo a repeat surgery due
o clinical deterioration and one patient clinically died.
Conclusion: The incidence of KPC gene at our hospi-
al was 7.5%. KPC positive isolatesare rapidly emerging
athogens. It is very important to keep this organism in mind
s if not treated there is a 100% probability of having a poor
utcome. There is a complete cross resistance to all Car-
apenems containing KPC, therefore if KPC is present, the
pneumoniae will be resistant to all Carbapenem regard-
ess of the routine susceptibility testing as shown in three
solates that are KPC positive but susceptible to Imipenem.
urrent automated systems used for susceptibility testing
ay not accurately identify all these isolates. We must also
ontrol the use of antibiotics specially PT to prevent emer-
ence of KPC positive organisms.
oi:10.1016/j.ijid.2010.02.1564
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n vitro activity of Tigecycline against molecularly deﬁned
arbapenemase producing Acinetobacter baumannii
. Hackel1,∗, P. Higgins2, H. Seifert2, S. Bouchillon1, B.
ohnson1, R. Badal1, J. johnson1, D. Hoban1, S. Hawser3,
. Dowzicky4
International Health Management Associates, Inc.,
chaumburg, IL, USA
Institute for Medical Microbiology, Cologne, Germany
IHMA Europe Sàrl, Epalinges, Switzerland
Pﬁzer Inc, Collegeville, PA, USA
Background: Acinetobacter baumannii are important
pportunistic pathogens with increasing rates of multi-
ntibiotic resistance due to both intrinsic and acquired
echanisms. Carbapenems are often used to treat these
nfections, however carbapenem resistance is increasingly
eported, leaving few therapeutic options. This resistance
s most often associated with acquired or intrinsic OXA-
roup carbapenemase production. While A. baumannii carry
he intrinsic OXA-51-like carbapenemase gene, carbapenem
esistance has only been associated with these genes when
he insertion sequence ISAba1 is upstream. In this study, we
valuated the in vitro activity of tigecycline against geneti-
ally deﬁned A. baumannii from the Tigecycline Evaluation
urveillance Trial.Methods: A total 352 imipenem resistant Acinetobacter
aumanii from 35 countries (2004 to 2006) were evaluated.
ICs were determined by broth microdilution and inter-
reted according to CLSI guidelines. Carbapenemase genes
ere detected by multiplex PCR.
